Related Experiment Video
Updated: Apr 16, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
[11C-choline PET/CT in the diagnosis of prostate cancer -- Hungarian experience]
Ildikó Garai1, Bence Farkas2, Attila Oszlánszki1
1ScanoMed Nukleáris Medicina Oktató és Kutató Kft., Debrecen, Hungary. garai.ildiko@scanomed.hu.
Abstract:
11C-choline has been used in the diagnosis and follow-up of patients with prostate cancer for years. Choline PET/CT has been available in human care since March, 2014 in our country. Unfortunately this examination has not been reimbursed by the National Health Insurance so far. We retrospectively analysed and assessed the results of 40 patients who underwent 11C-choline PET/CT on the basis of previous literature. As our study group was heterogeneous statistical analysis was not performed.

